Q2 Solutions completed the acquisition of Specifica.

Synopsis

Q2 Solutions, a global clinical trial laboratory services provider, completed the acquisition of Specifica, an antibody engineering and discovery services company. Financial terms were not disclosed.

Principals

target

SPECIFICA

bidder

Q2 Solutions

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

ken sharples

CEO at SPECIFICA

Manager

target

Deal

n/a

Total Value

Bidder Team (1)

brian o'dwyer

CEO at Q2 SOLUTIONS

Manager

bidder

Deals

£ 552 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy